Medtronic PLC
NYSE:MDT
Medtronic PLC
Cost of Revenue
Medtronic PLC
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Medtronic PLC
NYSE:MDT
|
Cost of Revenue
-$11.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-10%
|
|
Trinity Biotech PLC
NASDAQ:TRIB
|
Cost of Revenue
-$37.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
STERIS plc
NYSE:STE
|
Cost of Revenue
-$2.9B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
See Also
What is Medtronic PLC's Cost of Revenue?
Cost of Revenue
-11.1B
USD
Based on the financial report for Jan 26, 2024, Medtronic PLC's Cost of Revenue amounts to -11.1B USD.
What is Medtronic PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-10%
Over the last year, the Cost of Revenue growth was -8%. The average annual Cost of Revenue growth rates for Medtronic PLC have been -4% over the past three years , -4% over the past five years , and -10% over the past ten years .